Back to Search
Start Over
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
- Source :
- Neuro-Oncology; Mar2021, Vol. 23 Issue 3, p468-477, 10p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 23
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 149529886
- Full Text :
- https://doi.org/10.1093/neuonc/noaa240